Evidence map›Paper›PMID 41876372›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Coagulation Factors in Mexican Children, Young Adults and Older Adults.

Jessica Viviana Nieves-Hernández, Edgar Hernández-Zamora, Marlene Galicia-Alvarado, Armando Odiseo Rodríguez-Olivas, Erika Rosales-Cruz, Cesar Zavala-Hernández, Elba Reyes-Maldonado

Abstract read
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jessica Viviana Nieves-HernándezMorphology Department, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (ENCB, IPN), Mexico City, Mexico.
Edgar Hernández-ZamoraGenomic Medicine, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, México City, México (INR-LGII).ORCID 0000-0002-7511-4155
Marlene Galicia-AlvaradoClinical Neurosciences, INR-LGII, Ciudad de Mexico, Mexico.
Armando Odiseo Rodríguez-OlivasInstituto de Ciencias Biomédicas, Universidad Autónoma de Ciudad Juárez Campus Cuauhtémoc, Ciudad Cuauhtémoc, Chihuahua, México.ORCID 0000-0002-4447-8343
Erika Rosales-CruzMorphology Department, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (ENCB, IPN), Mexico City, Mexico.
Cesar Zavala-HernándezPathology Central Laboratory, INR-LGII, Mexico City, Mexico.
Elba Reyes-MaldonadoGenomic Medicine, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, México City, México (INR-LGII).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundThe diagnosis of bleeding disorders through the Clinical Chemistry Laboratory requires specific tests. In Mexico, there are few reports on reference values (RVs) for coagulation factors (CFs). The prevalence and RVs in adults and older Mexican adults have already been described. However, it remains unknown whether these parameters differ among minors (MI), young adults (YA), and older adults (OA). The aim of this study was to determine CF levels in a group of healthy MI, YA, and OA in Mexico.MethodsCFs were determined on a coagulation analyzer using commercial kits for the CFs: I, II, V, VII, VIII, IX, X, XI, and XII. The effect size was determined using Glass's rank biserial correlation coefficient. Comparisons between groups were performed using Dunn-Bonferroni post hoc tests following a significant Kruskal-Wallis test, and the epsilon-squared coefficient was used to estimate effect magnitude.Results347 participants, stratified by age group and sex, were studied. Variability in CF activity was observed. Age was found to be an important factor influencing the activity of all CFs, particularly factors II, V, VIII, IX, X, and XII, with factors V and XII proposed as biomarkers of aging.ConclusionsCF levels observed in OA differ from those in YA and MI, as well as from the RVs proposed in commercial kits. It is important to integrate these results into established diagnostic algorithms, as well as into an evidence-based practical guide that clinical personnel can use to support a comprehensive and accurate diagnosis of patients with hemostatic disorders.

Indexed as

Blood Coagulation FactorsAdolescentAdultAgedChildFemaleHumansMaleMexicoMiddle AgedReference ValuesYoung AdultBlood Coagulation Factorsadultschildrencoagulation factorslaboratoryreference values

Identifiers

PMID41876372
PMCPMC13013999

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.